Using a patient-centred composite endpoint in a secondary analysis of the Control of Hypertension in Pregnancy Study (CHIPS) Trial
Abstract Background Clinical trials commonly use multiple endpoints to measure the impact of an intervention. While this improves the comprehensiveness of outcomes, it can make trial results difficult to interpret. We examined the impact of integrating patient weights into a composite endpoint on th...
Main Authors: | Rebecca K. Metcalfe, Mark Harrison, Joel Singer, Mary Lewisch, Terry Lee, Peter von Dadelszen, Laura A. Magee, Nick Bansback, the CHIPS Study Group |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-02-01
|
Series: | Trials |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13063-023-07118-1 |
Similar Items
-
Surrogate endpoints in trials: a call for better reporting
by: Oriana Ciani, et al.
Published: (2022-12-01) -
Study of methods for endpoint aware inspection in a next generation firewall
by: Jenny Heino, et al.
Published: (2022-09-01) -
Physical function endpoints in cancer cachexia clinical trials: Systematic Review 1 of the cachexia endpoints series
by: James McDonald, et al.
Published: (2023-10-01) -
Role of degree and weighted coreness based on endpoints in link prediction
by: Jiaqi Hao, et al.
Published: (2022-10-01) -
When do we need clinical endpoint adjudication in clinical trials?
by: Claes Held
Published: (2019-01-01)